Cost-effectiveness/risk factors

Pediatrics. 2000 Aug;106(2 Pt 1):377-8. doi: 10.1542/peds.106.2.377-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibiotic Prophylaxis / economics*
  • Bacteremia / economics*
  • Bacteremia / prevention & control
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Pregnancy
  • Streptococcal Infections / economics*
  • Streptococcal Infections / prevention & control
  • Streptococcus agalactiae*